3 takeaways from TCT 2026

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 04 Nov, 16:10 UTC

Edwards’ TAVR device in moderate aortic stenosis drew applause from meeting attendees, while Medtronic’s renal denervation and Abbott’s left atrial appendage closure devices also produced positive study results.

science

Sources

• T23 takeaways from TCT 2026BioPharma Dive / Healthcare Dive / MedTech Dive04 Nov, 16:10